REGISTER FOR OUR VIRTUAL PRESENTATION – Nov 3, Clinical Trials Europe
eCOA SETUP: HOW TO ENSURE A SUCCESSFUL LAUNCH BY NAVIGATING COMPLEXITIES
- Prepare Specifications: how to mitigate risk and anticipate complexities
- User Acceptance Testing: who is responsible for performing the UAT and why?
- Selecting the eCOA back up strategy: how to make sure it will be adapted to every situation (even the unexpected ones?)
- How to keep the patient and the site at the heart of the decisions without jeopardizing data integrity?
This presentation will be held by Estelle Haenel, Medical Director at Kayentis.
Estelle has joined Kayentis, a global eCOA solutions provider, in 2019, to consolidate the scientific expertise of the company and drive patient and site centric developments.
Estelle has more than 20 years’ experience in the pharmaceutical industry, in both pre-clinical and clinical research. She joined Pfizer in early 2012 after having worked for both other big pharmas’ and biotech companies. She led projects from phase 1 through 4 in multiple therapeutic areas and has also solid expertise in the Non-Interventional space as well as in Clinical Pharmacology.
Last update : 14 October 2020